Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Revista Facultad Nacional de Salud Pública
versión impresa ISSN 0120-386X
Resumen
LEDEZMA-MORALES, Mónica; AMARILES, Pedro; VARGAS-PELAEZ, Claudia Marcela y ROSSI-BUENAVENTURA, Francisco Augusto. Strategies to promote access to medicines of interest in public health: structured review of the literature. Rev. Fac. Nac. Salud Pública [online]. 2020, vol.38, n.1, e332273. ISSN 0120-386X. https://doi.org/10.17533/udea.rfnsp.v38n1e332273.
Objective:
To identify strategies aimed to improve access to medicines of interest in public health with high cost or protected with patents, possibly applicable to the Colombian contextTo identify strategies aimed at promoting access to high-cost or patent-protected medicines of interest in public health, possibly applicable to the Colombian context..
Methodology:
structured review in PubMed/Medline, using the MeSH terms: “health services accessibility”, “pharmaceutical preparations”, “policy”, with filters for articles published in English and Spanish, between 2012 and 2017. Studies with information on strategies or policies that favored access to high-cost or patent-protected drugs of interest in public health were included. The strategies identified were grouped according to the five dimensions of access to health care and medicines defined by the World Health Organization: availability, affordability, accessibility, acceptability and quality.
Results:
62 articles were identified, of which 18 were included, and 5 additional references were considered. 30 strategies were recognised, distributed and classified according to the dimensions of access: availability and affordability, 15; accessibility, 6; acceptability, 6; quality, 2; cross-cutting strategy, 1.
Conclusions:
Key strategies were identified to favor access to high-cost or patent-protected medicines of interest in public health, including centralized price negotiations; public financial support for national research, development and production of generic medicines; the application of the flexibilities of the agreement on “Aspects of intellectual property rights related to trade” and the implementation of care programs.
Palabras clave : Accessibility to health services; health policy; medicine; intellectual property; medicine price.